IHS Chemical Week

Regions :: Southeast Asia

Lonza to Build Cell Therapy Production Facility in Singapore

12:19 AM MDT | May 19, 2009 | Deepti Ramesh

Lonza says it will build a new cell therapy manufacturing facility in Singapore to expand its global presence and to meet the growing worldwide demand for cell therapies. The facility will be located adjacent to Lonza’s large-scale mammalian manufacturing facility at Tuas Biomedical Park in Singapore. The first phase of the facility will involve an investment of SF30 million ($27 million). Construction of the facility will begin in early 2010 and it is expected to start manufacturing therapies in the first two suites by mid 2011. The facility will be...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa